Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06527794 · ClinicalTrials.gov registry record · NA
Remote Hypertension Management for Black Patients
A NA study of Uncontrolled Hypertension, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 864
- Enrollment target
- 1
- Study location
NCT06527794: Recruiting NA study of Uncontrolled Hypertension, sponsored by Wake Forest University Health Sciences.
NCT06527794 is a NA study of Uncontrolled Hypertension that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 864 participants, above the 678-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (27% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06527794, a NA study of Uncontrolled Hypertension, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 864 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare two approaches for managing hypertension in Black patients with uncontrolled blood pressure (BP). One approach will include home BP telemonitoring supported by a pharmacist and a community health worker. The other approach will include usual clinic-based care along with a home BP monitor and routine care.
Primary Outcome
Percent of patients achieving BP control (i.e., SBP\<130mmHg)
Conditions Studied
Interventions
- BEHAVIORAL RHYTHM (Remote Hypertension Tracking Help Management)
- BEHAVIORAL Enhanced usual care (UC)
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 864 participants |
| Start Date | 2024-12-13 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT06527794 shows while recruiting
NCT06527794 is an interventional study that assigns participants to a tested intervention. The registered 864 participants enrollment target is mid-sized for trials with a published cap, above the 678-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (27% higher).
The record links to 1 condition, with Uncontrolled Hypertension appearing as the primary indexed condition, and to 2 interventions - of which RHYTHM (Remote Hypertension Tracking Help Management) is the first listed.
NCT06527794 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06527794 about?
NCT06527794 is a clinical study titled "Remote Hypertension Management for Black Patients". This study will compare two approaches for managing hypertension in Black patients with uncontrolled blood pressure (BP). One approach will include home BP telemonitoring supported by a pharmacist and a community health worker. The other approach will include usual clinic-based care along with a hom...
What is the current status of trial NCT06527794?
This trial is currently recruiting. It is a NA study. The enrollment target is 864 participants. The study started on 2024-12-13. Estimated completion is 2028-09.
What conditions does trial NCT06527794 study?
This clinical trial studies the following conditions: Uncontrolled Hypertension.
What interventions are being tested in trial NCT06527794?
The interventions under investigation include: RHYTHM (Remote Hypertension Tracking Help Management) (BEHAVIORAL), Enhanced usual care (UC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06527794?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06527794 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uncontrolled Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06527794's enrollment target sits among peer trials
864 3rd of 10 higher than 8 of 10 other Uncontrolled Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uncontrolled Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
RECRUITING · NA
-
Renal Pelvic Denervation Pilot Trial
RECRUITING · NA
-
Wearable Evaluation of Ambulatory Readings for Blood Pressure
RECRUITING · NA
-
Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.
ACTIVE NOT RECRUITING · NA
-
Technology Coaching Intervention for Black Women With Hypertension
COMPLETED · NA
-
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06256588 · 864 participants · Phase 3
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- NCT05369052 · 865 participants · Phase 3
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
- NCT05914116 · 862 participants · Phase 1
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI